* Kills all pathogenic bacteria it comes in contact with, thus disallowing the development of resistant strains1
* Unlike broad spectrum antibiotics, it does not kill friendly bacteria such as Lactobacillus,
   leaving no side effects from interference with friendly bacteria 2
* Inactivates viruses at the DNA/RNA level through magnetic resonance, thus preventing virus replication3
* Does not interact with pharmaceuticals; in fact, has been found to work synergistically with medications4
* Enhances the immune system
* Is completely safe and non-toxic according to numerous safety studies

In addition to anti-bacterial uses, applications of BionicSil™ include:
* Hospital disinfectant (EPA approved)
* Inhibition of the growth of yeast
* Water treatment
* Successful treatment of malaria and many other human ailments
* Burn and wound treatment

Silver Research Supports Efficacy and Safety of New BionicSil™

In addition to rigorous clinical and hospital testing of BionicSil™, silver research conducted by many independent labs provides additional support for its effectiveness and safety. As two examples of efficacy, Brigham Young University Microbiology Laboratory has reported the following:

* When comparing the bio-availabilities of colloidal silver and this new silver, the range for the various colloidal solutions was 15% - 65%, while for the new silver was over 99%. This means that an individual would have to take six times as much 15% bio-available silver to absorb the same amount of silver in the new silver.

* When comparing the effectiveness of BionicSil™ to five different classes of antibiotics against seven different types of bacteria (E. coli B, E. aerogenes, E. cloacae, S. typhimunium, P. aeruginosa, S. gordonii and S. aureus), this BionicSil™ “was able to kill each bacteria tested. Not one of the antibiotics tested worked equally well on every bacterial strain that it was tested against.
BionicSil & Concerns of Argyria Associated with Colloidal Silver

Though unfounded, one of the hurdles that Silver has to overcome is a perceived connection to argyria. Argyria is a cosmetic condition (non life-threatening and non-debilitating) that has been associated with the overconsumption of colloidal silver/silver salt compounds of high concentration (30 – 300 ppm). The person’s skin takes on a bluish or grayish hue.
First of all, it must be stated that BionicSil™ differs from colloidal silver in many ways, including its concentration of the element12. Whereas older Silvers and suspensions contained up to 300,000 ppm (parts per million) of silver, BionicSil™ works very effectively at 5 – 30 ppm.

Considerable research has been conducted on the safety of this new silver, including studies by Dr. Ron Leavitt, NAMSA (an international medical testing laboratory) and Roger J. Altman, Ph.D., to name just a few. Altman consumed many times the recommended dosage of the new silver for nearly six months and found that silver “seems to be purged from the body (mostly through urine) at about the same rate at which it is consumed.


We encourage you to visit more pages and links on this site to read more silver research and to broaden your knowledge base about the benefits of this new anti-microbial solution.